Stockscreener 앱 받기
2.34
0.43%
0.010
전일 마감가:
$2.33
열려 있는:
$2.34
하루 거래량:
5.62M
Relative Volume:
0.65
시가총액:
$2.21B
수익:
$1.31M
순이익/손실:
$-597.65M
주가수익비율:
-2.4124
EPS:
-0.97
순현금흐름:
$-425.62M
1주 성능:
+1.30%
1개월 성능:
-7.87%
6개월 성능:
-18.18%
1년 성능:
-38.42%
1일 변동 폭
$2.29
$2.40
1주일 범위
$2.23
$2.425
52주 변동 폭
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
명칭
Immunitybio Inc
전화
(844) 696-5235
주소
3530 JOHN HOPKINS COURT, SAN DIEGO
IBRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.34 | 2.20B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 개시 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | BTIG Research | Buy |
| 2023-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 개시 | Jefferies | Buy |
Immunitybio Inc 주식(IBRX)의 최신 뉴스
Chart based analysis of ImmunityBio Inc. trendsJuly 2025 Summary & Community Verified Swing Trade Signals - Newser
Statistical indicators supporting ImmunityBio Inc.’s strengthQuarterly Risk Review & Low Risk High Reward Ideas - Newser
Real time scanner hits for ImmunityBio Inc. explained2025 Technical Patterns & Fast Entry Momentum Alerts - Newser
Will ImmunityBio Inc. bounce back from current support2025 Market Overview & Daily Price Action Insights - Newser
Using R and stats models for ImmunityBio Inc. forecastingDividend Hike & Free Accurate Trade Setup Notifications - Newser
Comparing ImmunityBio Inc. in custom built stock radars2025 Risk Factors & Expert Approved Trade Ideas - Newser
Advanced analytics toolkit walkthrough for ImmunityBio Inc.Market Risk Report & Low Volatility Stock Recommendations - Newser
Signal strength of ImmunityBio Inc. stock in tech scannersPortfolio Gains Report & Weekly Stock Performance Updates - Newser
ImmunityBio Inc. stock prediction for this weekJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
ImmunityBio Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - thegnnews.com
ImmunityBio Inc. stock volume spike explainedJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Will ImmunityBio Inc. benefit from macro trendsMarket Rally & Risk Managed Investment Strategies - Newser
ImmunityBio Inc. stock trendline breakdownRisk Management & Daily Profit Maximizing Tips - Newser
Key resistance and support levels for ImmunityBio Inc.Earnings Trend Report & Daily Technical Forecast Reports - Newser
How to build a custom watchlist for ImmunityBio Inc.Volume Spike & Long-Term Safe Investment Plans - Newser
ImmunityBio’s ANKTIVA: A Paradigm Shift in Glioblastoma Treatment with 100% Disease Control in Early Trials - AInvest
ImmunityBio (IBRX) Reports Initial Study Data Showing 100% Disease Control in Patients With Recurrent Glioblastoma - Yahoo Finance
Combining machine learning predictions for ImmunityBio Inc.Weekly Trend Recap & Free Technical Pattern Based Buy Signals - Newser
Advanced analytics toolkit walkthrough for ImmunityBio IncDividend Hike & AI Driven Stock Price Forecasts - Newser
Using Python tools to backtest ImmunityBio Inc. strategies2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser
Does ImmunityBio Inc. qualify in momentum factor screeningWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Applying chart zones and confluence areas to ImmunityBio Inc.Quarterly Earnings Summary & Daily Technical Forecast Reports - Newser
Will Volume Confirm Reversal in ImmunityBio Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Neuroendocrine tumors Pipeline Analysis, 2025 by DelveInsight | RayzeBio, Inc., Camurus, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp - Barchart.com
Is ImmunityBio Inc. stock a value trapJuly 2025 Drop Watch & Consistent Income Trade Ideas - sundaytimes.kr
Real time alert setup for ImmunityBio Inc. performanceGap Up & Weekly High Conviction Ideas - Newser
Institutional Tools Highlight Unusual Flow in ImmunityBio Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Immunitybio Inc (IBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):